A pproximately 780 000 people in the United States each year have a new or recurrent stroke, and 10% of these strokes result from carotid atherosclerosis. 1 Although atherosclerosis is common among older persons and increases with age, 2 the prevalence of clinically important stenosis is low. Routine screening generally is not recommended in asymptomatic patients, because fewer than 1% are likely to have clinically important atherosclerosis [3] [4] [5] and because the risk of complications outweighs the benefits. 6, 7 Nevertheless, the prevalence of clinically important carotid stenosis is higher among older patients with a history of peripheral vascular disease or coronary stenosis, so diagnostic imaging in these patients may be warranted. 8 Other common indications for carotid imaging include hemispheric stroke, transient ischemic attack with localizing symptoms or findings including amaurosis fugax, and follow-up of previously diagnosed atherosclerosis. [1] [2] [3] [4] Common methods of evaluating carotid stenosis include ultrasound, magnetic resonance angiography (MRA), and x-ray angiography (including noninvasive computed tomography [CT] angiography and invasive angiography). The benchmark method, digital subtraction cerebral angiography, is associated with some risk. Noninvasive tests such as ultrasound and MRA carry less risk but may not be as accurate and, in the case of MRA, are more expensive.
Since 2000, diagnostic imaging among Medicare beneficiaries has increased 5.9% per year, and expenditures for diagnostic imaging have increased more than 11% per year. 9 Together, nonechocardiography ultrasound, CT, and magnetic resonance imaging (MRI) accounted for almost 50% of imaging expenditures under the Medicare physician fee schedule in 2005. 10 Diagnostic imaging among Medicare beneficiaries is an important contributor to rising health care costs. 11 However, little is known about recent trends in the use of carotid imaging. Moreover, evidence of benefit for asymptomatic patients with carotid stenosis 12 and the recent introduction of alternative revascularization methods such as carotid stenting may have altered the thresholds for the appropriateness of diagnostic imaging. Therefore, we examined trends and geographic variation in the use of carotid imaging from 2001 through 2006.
WHAT IS KNOWN
• Routine screening for carotid atherosclerosis generally is not recommended because clinically important atherosclerosis is uncommon.
• Diagnostic imaging among Medicare beneficiaries has grown markedly during the last decade, but little is known about recent trends in the use of carotid imaging.
WHAT THE STUDY ADDS
• The use of carotid imaging among Medicare beneficiaries increased substantially from 2001 through 2006.
• Although ultrasound remained the dominant method of imaging throughout the time period, there was a sharp rise in carotid magnetic resonance angiography.
• The increase in imaging was accompanied by a slight decline in the age-adjusted rate of carotid interventions.
Methods

Data Sources
We analyzed a 5% national sample of data from the Medicare inpatient, outpatient, and carrier standard analytic files and the corresponding denominator files. We obtained research-identifiable files for January 1, 1999, through December 31, 2006, from the Centers for Medicare and Medicaid Services (CMS). Institutional claims for facility costs covered under Medicare Part A are included in the inpatient files. Claims from outpatient providers are included in the outpatient files, and noninstitutional provider claims for services covered under Medicare Part B are included in the carrier files. The denominator files include beneficiary demographic characteristics, dates of death, and program eligibility and enrollment information. We limited the analysis to beneficiaries living in the United States who were 65 years or older. Only claims filed during periods of fee-for-service coverage were included. The institutional review board of the Duke University Health System approved the study.
Study Cohort Definitions
We selected all Medicare beneficiaries between January 
Study Variables
We searched the carrier files for the period January 
Patient Characteristics
Demographic characteristics available for this analysis included age, sex, race, and state of residence. Medicare beneficiaries report race at the time of enrollment. We used the reported category "black" and combined all others as "nonblack," consistent with a previously published analysis. 13 Because there was insufficient volume to estimate rates at the state level, we used the beneficiary state codes in the denominator file for each year to group beneficiaries into 9 US Census regions. We identified comorbid conditions using previously described coding algorithms. 14 
Statistical Analysis
For the baseline characteristics of the patients, we present categorical variables as percentages and continuous variables as means with standard deviations. We calculated rates of use per 1000 personyears. Person-years were calculated as the total days alive and enrolled in fee-for-service Medicare and accounting for gaps in enrollment. We used the direct standardization method to calculate annual age-adjusted rates of ultrasound, MRA, x-ray angiography, and carotid interventions and to calculate age-adjusted rates of carotid imaging by geographic region. We used the pooled population as the standard population for age adjustment. We limited the cohort of eligible beneficiaries to those with 12 previous months of Medicare eligibility and used logistic regression models to measure the independent effects of age, sex, race, comorbid conditions, geographic region, and year on the use of ultrasound, MRA, and x-ray angiography. For all analyses, the data for each year were considered a cross-sectional panel. We used SAS version 9.1.3 (SAS Institute Inc, Cary, NC) for all analyses.
Results
In each year from 2001 through 2006, the Medicare 5% sample included approximately 1.4 million persons 65 years or older. In 2001, slightly less than half of the eligible beneficiaries had a prior diagnosis of coronary artery disease, peripheral vascular disease, or cerebrovascular disease and thus were included in the vascular disease cohort (Table 1) . Nearly 60% of patients in the vascular disease cohort were 75 years or older, compared with 37% of patients without a history of vascular disease. The geographic distribution of the 2 cohorts was similar. The demographic distributions of the 2002 through 2006 cohorts were similar to those of the 2001 cohorts (data not shown).
Trends in Carotid Imaging
Overall age-adjusted rates of carotid imaging increased by 27% from 98. Although the absolute rate remained low, the rate of MRA increased by 51% (1.1 to 1.6 per 1000 person-years).
Geographic Variation
Imaging rates were lowest in the New England and Mountain regions and highest in the Middle Atlantic and South Atlantic regions ( Table 3 In the vascular disease cohort, the patterns of geographic variation were similar to the patterns among all beneficiaries. Rates of carotid imaging were highest in the Middle Atlantic and South Atlantic regions and lowest in the New England, Mountain, and West North Central regions (data not shown). In 2006, rates of carotid ultrasound were highest in the Middle Atlantic region (220 per 1000 person-years) and lowest in New England (163 per 1000 person-years).
Predictors of Carotid Imaging
The adjusted odds of undergoing carotid imaging of any kind were highest among persons ages 75 to 79 years compared with persons ages 65 to 69 years (Table 4) . For black patients, the odds were 29% lower (odds ratio [OR], 0.71; 95% confidence interval [CI], 0.70 to 0.72) for carotid ultrasound, 21% lower (OR, 0.79; 95% CI, 0.77 to 0.82) for MRA, and 44% lower (OR, 0.56; 95% CI, 0.53 to 0.59) for x-ray angiography compared with nonblack patients. Coronary artery disease, peripheral vascular disease, and cerebrovascular disease increased the odds of undergoing carotid imaging significantly, whereas dementia was associated with significantly lower odds. Geographic differences persisted after adjustment for demographic characteristics, comorbid conditions, and study year.
Discussion
From 2001 through 2006, carotid imaging among Medicare beneficiaries increased more than 25%. Ultrasound was the dominant method, but the use of MRA increased most rapidly. Despite the increase in testing, the age-adjusted rate Among patients with vascular disease, carotid ultrasound was used in approximately 1 in 5 patients, and the increase in its use was modest. In contrast, the use of MRA among these patients increased by more than 50%, and the use of x-ray angiography increased by 37%. There was substantial growth in carotid imaging in all geographic regions, but use of the 3 imaging modalities varied considerably by region. In all regions, ultrasound was the preferred modality, but the rate in 2006 was nearly 60% higher in the Middle Atlantic region than in the Mountain and New England regions. The rate of carotid MRA was 64% higher in the New England and Middle Atlantic regions than in the West North Central region. Although the findings are consistent with guidelines that favor ultrasound and MRI over CT of peripheral arteries, 16 there was significant variability in the modalities used to evaluate carotid artery disease.
Consistent with overall trends in imaging services reimbursed by Medicare, 11 more rapid growth has occurred in the more advanced imaging modality. Among patients with a history of vascular disease, the use of MRA increased by 56%, whereas the use of carotid ultrasound increased by 15%. A 2008 Government Accountability Office report highlighted the disproportionate growth in spending on advanced imaging techniques compared with ultrasound and x-ray. 11 From 2000 through 2006, spending on advanced imaging increased at an average annual rate of 17%, nearly twice the rate for less advanced modalities.
Many factors probably contribute to the increasing use of carotid imaging. Imaging equipment is more accessible and devices are smaller, portable, and increasingly available in outpatient settings. 11, 17 From 1999 through 2004, the estimated number of MRI units in the United States more than doubled. 11 A recent analysis suggests that each additional MRI unit is associated with more than 700 additional MRI scans among Medicare beneficiaries. 18 With each additional MRI unit, the number of beneficiaries who received an examination increased by more than 400.
Rising disease prevalence may also have contributed to the increase in imaging rates. Risk factors for carotid artery stenosis include peripheral vascular disease, heart disease, smoking, hypertension, age, and diabetes mellitus. 19 -23 We observed a 9% increase in the number of Medicare beneficiaries with a recent history of vascular disease. Within that group, however, the rate of imaging increased by 18%, suggesting that increasing use is fueled by more than rising disease prevalence. Because increasing testing rates will lead to an apparent increase in disease prevalence, it is difficult to ascertain from claims data whether increasing prevalence is the cause or effect of increasing test rates. Furthermore, our findings suggest that the increasing use of carotid imaging has not translated into greater use of therapeutic interventions. The rate of carotid ultrasound increased by 23% while the rate of carotid interventions fell by 13%. In 2001, 1 carotid intervention was performed for every 25 carotid ultrasound examinations; by 2006, 1 intervention was performed for every 35 ultrasound examinations. Carotid imaging can help clinicians understand the pathophysiology of patients' signs and symptoms, so its use in patients who are not candidates for intervention may be justified. 24 However, the reduction in the yield of carotid ultrasound examinations in terms of interventions suggests that imaging is being overused.
Geographic variations in the use of carotid imaging further support the conclusion that imaging is overused or misused in some areas. The rate of carotid imaging was 50% higher in the Middle Atlantic region than in the West North Central and Mountain regions. Geographic variations were also present in the vascular disease cohort, suggesting that the variation does not simply reflect regional differences in disease prevalence. Our findings also support the possibility that carotid imaging has been underused in some groups of patients. In multivariable analyses, black patients were significantly less likely than nonblack patients to undergo carotid imaging. An analysis of Veterans Affairs Health Administration data found no racial differences in the use of carotid ultrasound among 775 patients hospitalized with acute ischemic stroke. 25 To our knowledge, ours is the first study to examine racial differences in the use of carotid imaging among Medicare beneficiaries.
Although we found that patients at higher risk for carotid artery disease are more likely to undergo imaging tests, the observed geographic variation and increasing rates over time underscore the need for clear guidance regarding the appropriate use of carotid imaging. In response to the concerns of patients, clinicians, and payers about the increasing costs and potential overuse of medical technologies, the American The multivariable models included all of the variables listed. *See Table 1 for definitions of geographic regions.
College of Cardiology and other professional societies have developed reviews of appropriateness criteria to provide guidance toward reasonable indications for use and reimbursement. 16, 26 Carotid imaging may be a good candidate for such evaluation.
Limitations
Our analysis has some limitations. First, to identify patients with a recent history of vascular disease, we relied on diagnoses recorded in administrative data, which may be incomplete. Second, indications for imaging studies are not recorded in Medicare claims. Third, we avoided doublecounting imaging studies by counting 1 study per patient per place of service per day in each category (ie, ultrasound, MRA, and x-ray angiography). To the extent that some patients underwent multiple examinations on a single day, for example, our approach may have underestimated utilization. Third, Medicare claims are filed for fee-for-service beneficiaries only, so the generalizability of our findings to all Medicare beneficiaries is unclear.
Conclusion
From 2001 through 2006, there was a substantial increase in the use of carotid imaging among Medicare beneficiaries, including a sharp rise in the use of carotid MRA, and a concurrent decrease in the use of carotid revascularization procedures. Geographic variations were substantial and were present in the subset of patients with a recent history of vascular disease. These findings highlight the need for clinical guidance regarding the appropriate use of carotid imaging.
